Hormone inhibitor promising for hard-to-treat prostate cancer

For prostate cancer patients whose tumors have continued to grow despite medical or surgical castration, a new drug candidate that inhibits production of male hormones anywhere in the body is showing promise in early trials.

If you want to include this story in your blog, copy and paste this formatted text: